NVO - Novo Nordisk A/S
NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 135.45B |
| Enterprise value 3 | 135.61B |
| Trailing P/E | 23.25 |
| Forward P/E 1 | 21.36 |
| PEG ratio (5-yr expected) 1 | 2.48 |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 18.61 |
| Enterprise value/revenue 3 | N/A |
| Enterprise value/EBITDA 6 | N/A |
Trading information
Stock price history
| Beta (5Y Monthly) | 0.59 |
| 52-week change 3 | 22.32% |
| S&P500 52-week change 3 | 24.46% |
| 52-week high 3 | 58.01 |
| 52-week low 3 | 43.60 |
| 50-day moving average 3 | 56.37 |
| 200-day moving average 3 | 52.10 |
Share statistics
| Avg vol (3-month) 3 | 1.42M |
| Avg vol (10-day) 3 | 1.42M |
| Shares outstanding 5 | 2.35B |
| Float | 1.68B |
| % held by insiders 1 | 0.02% |
| % held by institutions 1 | 9.41% |
| Shares short (29 Nov 2019) 4 | 5M |
| Short ratio (29 Nov 2019) 4 | 3.19 |
| Short % of float (29 Nov 2019) 4 | N/A |
| Short % of shares outstanding (29 Nov 2019) 4 | 0.21% |
| Shares short (prior month 31 Oct 2019) 4 | 6.57M |
Dividends & splits
| Forward annual dividend rate 4 | 1.25 |
| Forward annual dividend yield 4 | 2.21% |
| Trailing annual dividend rate 3 | 1.23 |
| Trailing annual dividend yield 3 | 2.17% |
| 5-year average dividend yield 4 | 2.31 |
| Payout ratio 4 | 32.38% |
| Dividend date 3 | 27 Aug 2019 |
| Ex-dividend date 4 | 22 Mar 2019 |
| Last split factor (new per old) 2 | 1/5 |
| Last split date 3 | 9 Jan 2014 |
Financial highlights
Currency in DKK.Fiscal year
| Fiscal year ends | 31 Dec 2018 |
| Most-recent quarter (mrq) | 30 Sep 2019 |
Profitability
| Profit margin | 32.46% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | 28.26% |
| Return on equity (ttm) | 77.10% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | 9.10% |
| Gross profit (ttm) | 94.21B |
| EBITDA | N/A |
| Net income avi to common (ttm) | N/A |
| Diluted EPS (ttm) | 2.46 |
| Quarterly earnings growth (yoy) | 12.80% |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | 8.20 |
| Current ratio (mrq) | 1.00 |
| Book value per share (mrq) | 3.08 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |